AK
Therapeutic Areas
PathAI Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AIM-PDL1 | Various Cancers (Immunotherapy Biomarker) | Development/Commercial |
| AIM-HER2 | Breast Cancer | Development/Commercial |
| AIM-MASH | Metabolic dysfunction-Associated Steatohepatitis | FDA Qualified for Trials |
| AIM-HI-UC | Ulcerative Colitis | Clinical Trials |
| AISight® Dx | Primary Diagnosis (Platform) | FDA Cleared |